News
03-14-2016, 02:15 PM
Addition of lapatinib to trastuzumab improves responses in women with newly diagnosed, HER2-positive breast cancer who receive the combination prior to undergoing surgery, suggests research.
More... (http://www.news-medical.net/news/20160314/Preoperative-lapatinib-plus-trastuzumab-elicits-response-in-HER2-positive-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20160314/Preoperative-lapatinib-plus-trastuzumab-elicits-response-in-HER2-positive-breast-cancer.aspx)